Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sally S. Clive"'
Autor:
Jean-Luc Van Laethem, Brenda B. Tromp, Jessica Vermeulen, Josep Tabernero, Brett Hall, Neil N. Steven, Sally S. Clive, Rajesh Bandekar, Eric Angevin, Thomas A. Puchalski, Isabelle Ray-Coquard, Christian C. Ottensmeier, Jose A. Lopez-Martin, Elena Elez, Luc Dirix, Jean-Pascal Machiels, Razelle Kurzrock, Rastilav Bahleda, Helgi van de Velde, Florence Joly, Steven Cohen, Manjula Reddy
Publikováno v:
Clinical Cancer Research. 20:2192-2204
Purpose: This phase I/II study evaluated safety, efficacy, and pharmacokinetics of escalating, multiple doses of siltuximab, a chimeric anti-interleukin (IL)-6 monoclonal antibody derived from a new Chinese hamster ovary (CHO) cell line in patients w
Autor:
Harvey S; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK., Stares M; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK.; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Scott JA; Experimental Cancer Medicine Team (ECMT), The Christie NHS Foundation Trust, Manchester, UK., Thottiyil TJV; University College London Hospitals NHS Foundation Trust, London, UK., Conway AM; The University of Manchester, Cancer Research UK Manchester Institute, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Haigh R; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Brown J; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Knowles G; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Dasgupta S; Velindre University NHS Trust, Cardiff, UK., Shiu KK; University College London Hospitals NHS Foundation Trust, London, UK., Mitchell C; The Christie NHS Foundation Trust, Manchester, UK., Barrie C; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Cook N; Experimental Cancer Medicine Team (ECMT), The Christie NHS Foundation Trust, Manchester, UK., Clive S; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6988.
Autor:
Stares M; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK.; University of Edinburgh, Edinburgh, UK., Purshouse K; University of Edinburgh, Edinburgh, UK., Knowles G; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK., Haigh R; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK., Irvine J; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK., Gatenby A; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK., Patton R; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK., McGinty J; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK., Christie A; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK., MacLennan M; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK., Barrie C; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK., Clive S; Edinburgh Cancer Centre, Western General Hospital, NHS Lothian, Edinburgh, UK. sally.clive@nhslothian.scot.nhs.uk.
Publikováno v:
British journal of cancer [Br J Cancer] 2021 Nov; Vol. 125 (11), pp. 1503-1510. Date of Electronic Publication: 2021 Sep 06.
Autor:
Pallmann P; Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK., Wan F; Department of Mathematics & Statistics, Lancaster University, Lancaster, UK., Mander AP; Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK., Wheeler GM; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, UK., Yap C; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Clive S; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Hampson LV; Statistical Methodology, Novartis Pharma AG, Basel, Switzerland., Jaki T; Department of Mathematics & Statistics, Lancaster University, Lancaster, UK.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2020 Apr; Vol. 17 (2), pp. 147-156. Date of Electronic Publication: 2019 Dec 19.
Autor:
Woodcock VK; University of Oxford Department of Oncology, Churchill Hospital, Old Road, Oxford OX3 7LJ, UK., Clive S; Edinburgh Cancer Centre, Western General Hospital, Edinburgh EH4 2XU, UK., Wilson RH; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Lisburn Road, Belfast BT9 7AE, Northern Ireland, UK., Coyle VM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Lisburn Road, Belfast BT9 7AE, Northern Ireland, UK., Stratford MRL; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK., Folkes LK; Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK., Eastell R; Academic Unit of Bone Metabolism, University of Sheffield, Sheffield S10 2TN, UK., Barton C; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Jones P; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Kazmi-Stokes S; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Turner H; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Halford S; Cancer Research UK Centre for Drug Development, Cancer Research UK, Angel Building, 407 St. John Street, London EC1V 4AD, UK., Harris AL; University of Oxford Department of Oncology, Churchill Hospital, Old Road, Oxford OX3 7LJ, UK., Middleton MR; University of Oxford Department of Oncology, Churchill Hospital, Old Road, Oxford OX3 7LJ, UK.; National Institute for Health Research Oxford Biomedical Research Centre, Oxford OX3 7LE, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2018 Mar 20; Vol. 118 (6), pp. 770-776. Date of Electronic Publication: 2018 Feb 13.
Autor:
Love SB; Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, NDORMS, University of Oxford, Botnar Research Centre, Windmill Road, Oxford OX3 7LD, UK., Brown S; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds LS2 9JT, UK., Weir CJ; Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK., Harbron C; Roche Pharmaceuticals, 6 Falcon Way, Shire Park, Welwyn Garden City AL7 1TW, UK., Yap C; Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK., Gaschler-Markefski B; Boehringer Ingelheim Pharma GmbH &Co. KG, Biostatistics and Data Sciences, Birkendorfer Strasse 65, Biberach an der Riss 88400, Germany., Matcham J; AstraZeneca, DaVinci Building, Melbourn Science Park, Royston SG8 6HB, UK., Caffrey L; School of Social Work and Social Policy, Trinity College Dublin, College Green, Dublin 2, Ireland., McKevitt C; Division of Health and Social Care Research, Faculty of Life Sciences and Medicine, King's College London, London, UK., Clive S; Edinburgh Cancer Centre, Western General Hospital, Edinburgh EX4 2XU, UK., Craddock C; Centre for Clinical Haematology, Haematology - University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Queen Elizabeth Medical Centre, Birmingham B15 2TH, UK., Spicer J; Division of Cancer Studies, Bermondsey Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK., Cornelius V; Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2017 Jul 25; Vol. 117 (3), pp. 332-339. Date of Electronic Publication: 2017 Jun 29.
Autor:
McCann KJ; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK., Mander A; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK., Cazaly A; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK., Chudley L; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK., Stasakova J; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK., Thirdborough S; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK., King A; University Hospital Southampton NHS Trust, Southampton, UK., Lloyd-Evans P; NHS Blood and Transplant, Clinical Biotechnology Centre, University of Bristol, Bristol, UK., Buxton E; Cancer Research UK Centre for Drug Development, London, UK., Edwards C; Cancer Research UK Centre for Drug Development, London, UK., Halford S; Cancer Research UK Centre for Drug Development, London, UK., Bateman A; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK.; University Hospital Southampton NHS Trust, Southampton, UK., O'Callaghan A; Portsmouth Hospitals NHS Trust, Portsmouth, UK., Clive S; Western General Hospital, Edinburgh, UK., Anthoney A; St. James's Institute of Oncology, Leeds, UK., Jodrell DI; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Weinschenk T; Immatics biotechnologies, Tübingen, Germany., Simon P; TRON gGmbH, Translational Oncology at the University Medical Center, Johannes Gutenberg-University, Mainz, Germany.; BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Sahin U; TRON gGmbH, Translational Oncology at the University Medical Center, Johannes Gutenberg-University, Mainz, Germany., Thomas GJ; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK.; University Hospital Southampton NHS Trust, Southampton, UK., Stevenson FK; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK., Ottensmeier CH; Southampton Experimental Cancer Medicine Centre, Cancer Sciences Unit, University of Southampton, Southampton, UK.; University Hospital Southampton NHS Trust, Southampton, UK.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Oct 01; Vol. 22 (19), pp. 4827-4836. Date of Electronic Publication: 2016 Apr 18.
Autor:
Ridoux L; aSanofi R&D, Chilly-Mazarin bSanofi R&D, Vitry-sur-Seine, France cSanofi R&D, Cambridge, Massachusetts, USA dCharles River Biopharmaceutical Services, Tranent eEdinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Sémiond DR, Vincent C, Fontaine H, Mauriac C, Sanderink GJ, Oprea C, Kelly L, Clive S
Publikováno v:
Anti-cancer drugs [Anticancer Drugs] 2015 Mar; Vol. 26 (3), pp. 350-8.
Autor:
Slingerland M; Department of Clinical Oncology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands, m.slingerland@lumc.nl., Hess D, Clive S, Sharma S, Sandstrom P, Loman N, Porro MG, Mu S, Waldron E, Valera SZ, Gelderblom H
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2014 Nov; Vol. 74 (5), pp. 1089-98. Date of Electronic Publication: 2014 Sep 25.
Autor:
Angevin E; Authors' Affiliations: Institut de Cancérologie Gustave Roussy, Villejuif; Centre Francois Baclesse, CHU Côte de Nacre, Caen; Centre Léon Bérard Lyon, Lyon, France; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona; 12 de Octubre University Hospital, Madrid, Spain; Fox Chase Cancer Center, Philadelphia; Janssen Research & Development, Spring House, Pennsylvania; formerly University of Texas, MD Anderson Cancer Center, Houston, Texas; currently UC San Diego Moores Cancer Center, San Diego, California; Erasme University Hospital; Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels; AZ Sint-Augustinus, Antwerp; Janssen Research & Development, Beerse, Belgium; Southampton University Hospitals NHS Trust, Southampton; Western General Hospital, Edinburgh; University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom; and Janssen Research & Development, Leiden, the Netherlands., Tabernero J, Elez E, Cohen SJ, Bahleda R, van Laethem JL, Ottensmeier C, Lopez-Martin JA, Clive S, Joly F, Ray-Coquard I, Dirix L, Machiels JP, Steven N, Reddy M, Hall B, Puchalski TA, Bandekar R, van de Velde H, Tromp B, Vermeulen J, Kurzrock R
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2014 Apr 15; Vol. 20 (8), pp. 2192-204. Date of Electronic Publication: 2014 Feb 21.